Reimbursement

A New Way to Process, Distribute and Service Members

Simplified Claims Processing

HCP-Governed CGM Administration

Improved Member Experience

ICD-10 Coding And Billing

Eversense is indicated for adults with insulin-dependent diabetes, using all applicable ICD-10-CM codes based on the complexity of the diagnosis.

Category III CPT Codes

Three specific Category III CPT codes are required to report the implantation and/or removal of the Eversense Sensor. Please note some other payers may not cover these codes, making prior authorization necessary. These codes are:



Need More Information?

REQUEST INFO

Become a Provider

Learn More

Read Our Reimbursement Resource

LEARN MORE

Medicare Patients

Learn More

Category I CPT Code For CGM Analysis And Interpretation

Providers may also represent their analysis and interpretation of Eversense data using:

* The individual in this video has been sponsored by Senseonics to appear in the video. The opinions expressed belong solely to the individual. This information provides general information only. It is not intended to be used as medical advice, diagnosis or treatment and should not replace the advice of a Health Care Provider. A Health Care Provider must be consulted and the device user manual reviewed in full before use. Individual results may vary, testimonials are not claimed to represent typical results. All testimonials are not intended to represent or guarantee that anyone will achieve the same or similar results

** Subject to commercial insurance approval and a valid prescription

 

Disclaimer

The Eversense® E3 Continuous Glucose Monitoring (CGM) System is indicated for continually measuring glucose levels for up to 180 days in persons with diabetes age 18 and older. The system is indicated for use to replace fingerstick blood glucose (BG) measurements for diabetes treatment decisions. Fingerstick BG measurements are still required for calibration primarily one time a day after day 21, and when symptoms do not match CGM information or when taking medications of the tetracycline class. The sensor insertion and removal procedures are performed by a health care provider. The Eversense E3 CGM System is a prescription device; patients should talk to their health care provider to learn more.
For safety information click here.

Eversense, Eversense E3 Continuous Glucose Monitoring and the Eversense logo are trademarks of Senseonics, Incorporated. Ascensia, and the Ascensia Diabetes Care logo are trademarks and/or registered trademarks of Ascensia Diabetes Care Holdings AG. All other trademarks are properties of their respective owners and are used solely for informative purposes. No relationship or endorsement should be inferred or implied.

Apple Watch® is a product of Apple, Inc., and may be separately purchased from an authorized Apple retailer. Apple Watch is not included with the Eversense CGM System. Android is a trademark of Google LLC.